Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • Country/Region
    • Clinic Portal
      • +0034963905310
    • Request Information
    • +34 96 390 53 10
    • Part of brands: |
    InternationalInternational
    • Country/Region
      • Part of brands: |
      • We guide you
        • Fertility
          • What to do if…
        • Prevent Inherited Diseases
          • Carrier Genetic Test
        • Worry-free Pregnancy
          • NACE
          • Prenatal Diagnostics
          • Newborn Health
      • Reproductive Health
        • Specialists
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • POC
          • SAT
          • Newborn Screening
        • Patients
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • SAT
          • POC
      • Diagnostics
      • About us
        • Igenomix Research
        • About Igenomix
        • Igenomix Worldwide
      • Academy
      • Blog
      Genomics Precision Diagnostic > Neurology Precision Panel > Hyperekplexia Precision Panel

      Hyperekplexia Precision Panel

      Hyperekplexia, also known as stiff baby syndrome or startle disease, is a rare hereditary neurological disease associated to a variety of gene mutations that affect the glycine receptor. This disorder is characterized by a triad of generalized stiffness while awake, nocturnal myoclonus and exaggerated startle reflex.
      Overview
      Indication
      Clinical Utility
      Genes & Diseases
      Methodology
      References

      Overview

      • Hyperekplexia, also known as stiff baby syndrome or startle disease, is a rare hereditary neurological disease associated to a variety of gene mutations that affect the glycine receptor. This disorder is characterized by a triad of generalized stiffness while awake, nocturnal myoclonus and exaggerated startle reflex. These features often appear at birth alongside episodes of hypertonia or tonic spasms upon awakening. When severe, it may interfere with breathing causing irreversible brain damage. Hyperekplexia is usually misdiagnosed as a form epilepsy. It is inherited mostly as an autosomal dominant trait but can also follow autosomal recessive or X-linked inheritance. 

      • The Igenomix Hyperekplexia Precision Panel  can serve as an accurate and directed diagnostic tool as well as a differential diagnosis of seizures ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.

      Indication

      • The Igenomix Hyperekplexia Precision Panel is indicated in patients with a clinical suspicion or diagnosis presenting with or without the following manifestations: 
        • Arching of the head alongside the startle reaction 
        • Jerking movements after startle reaction 
        • Severe muscle tension 
        • Lack of movement or slower than normal 
        • Overactive reflexes 
        • Intermittent apnea 
        • Unsteady gait 

      Clinical Utility

      The clinical utility of this panel is: 

      • The genetic and molecular diagnosis for an accurate clinical diagnosis of a symptomatic patient.    
      • Early initiation of treatment with a multidisciplinary team in the form of pharmacologic therapy with antiepileptic drugs such as clonazepam. 
      • Risk assessment and genetic counselling of asymptomatic family members according to the mode of inheritance. 
      • Improvement of delineation of genotype-phenotype correlation.

      Genes & Diseases

      Methodology

      References

      See scientific referrals

      Andrew, M., & Owen, M. (1997). Hyperekplexia: abnormal startle response due to glycine receptor mutations. British Journal Of Psychiatry, 170(2), 106-108. doi: 10.1192/bjp.170.2.106 

      Bakker, M., van Dijk, J., van den Maagdenberg, A., & Tijssen, M. (2006). Startle syndromes. The Lancet Neurology, 5(6), 513-524. doi: 10.1016/s1474-4422(06)70470-7 

      Zhou, L., Chillag, K., & Nigro, M. (2002). Hyperekplexia: a treatable neurogenetic disease. Brain And Development, 24(7), 669-674. doi: 10.1016/s0387-7604(02)00095-5 

      Ryan, S. (1994). Hyperekplexia Associated With Apnea and Sudden Infant Death Syndrome. Archives Of Pediatrics & Adolescent Medicine, 148(5), 540. doi: 10.1001/archpedi.1994.02170050098025 

      Mineyko, A., Whiting, S., & Graham, G. E. (2011). Hyperekplexia: treatment of a severe phenotype and review of the literature. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 38(3), 411–416. https://doi.org/10.1017/s0317167100011793 

      Thomas, R. H., Chung, S. K., Wood, S. E., Cushion, T. D., Drew, C. J., Hammond, C. L., Vanbellinghen, J. F., Mullins, J. G., & Rees, M. I. (2013). Genotype-phenotype correlations in hyperekplexia: apnoeas, learning difficulties and speech delay. Brain : a journal of neurology, 136(Pt 10), 3085–3095. https://doi.org/10.1093/brain/awt207 

      descargar

      Detail description

      Download

      Request Information


      WE GUIDE YOU

      Fertility
      Inherited diseases prevention
      Healthy pregnancy

      To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

      OUR SERVICES

      Genetic solutions
      For patients
      How to send a sample?
      User manual

      ABOUT US

      About Igenomix
      Contact
      Quality
      Complaints
      Work with us

      FOLLOW IGENOMIX

        + 96 390 53 10
        Write us
      • Argentina
      • Brazil
      • Canada
      • Chile
      • Colombia
      • Europe
      • France
      • Germany
      • India
      • Italy
      • Japan
      • Korea
      • Mexico
      • Perú
      • Russia
      • Spain
      • Taiwan
      • The Middle East
      • Turkey
      • United Kingdom
      • United States
      • Vietnam
      Country/Region

      [2021] © Igenomix Privacy policy Quality policy Legal note Cookies policyNews and Press

      Request Information

















      • We guide you
        • Fertility
          • What to do if…
        • Prevent Inherited Diseases
          • Carrier Genetic Test
        • Worry-free Pregnancy
          • NACE
          • Prenatal Diagnostics
          • Newborn Health
      • Reproductive Health
        • Specialists
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • POC
          • SAT
          • Newborn Screening
        • Patients
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • SAT
          • POC
      • Diagnostics
      • About us
        • Igenomix Research
        • About Igenomix
        • Igenomix Worldwide
      • Academy
      • Blog
      • Country/Region
      • +34 96 390 53 10
      • Clinic Portal
      • Request Information

      We are using cookies to give you the best experience on our website.

      You can find out more about which cookies we are using or switch them off in settings.

      International
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

      3rd Party Cookies

      This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

      Keeping this cookie enabled helps us to improve our website.

      Please enable Strictly Necessary Cookies first so that we can save your preferences!

      Cookie Policy

      More information about our Cookie Policy